Małgorzata Bobrowicz

688 total citations
25 papers, 341 citations indexed

About

Małgorzata Bobrowicz is a scholar working on Immunology, Oncology and Dermatology. According to data from OpenAlex, Małgorzata Bobrowicz has authored 25 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 9 papers in Dermatology. Recurrent topics in Małgorzata Bobrowicz's work include CAR-T cell therapy research (11 papers), Cutaneous lymphoproliferative disorders research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Małgorzata Bobrowicz is often cited by papers focused on CAR-T cell therapy research (11 papers), Cutaneous lymphoproliferative disorders research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Małgorzata Bobrowicz collaborates with scholars based in Poland, Switzerland and Austria. Małgorzata Bobrowicz's co-authors include Magdalena Winiarska, Emmanuella Guenova, Małgorzata Firczuk, Joanna Stachura, Yun‐Tsan Chang, Klaudyna Fidyt, Desislava Ignatova, Antoni Domagała, Christina Fassnacht and Florentia Dimitriou and has published in prestigious journals such as Nature Communications, Blood and International Journal of Molecular Sciences.

In The Last Decade

Małgorzata Bobrowicz

23 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Małgorzata Bobrowicz Poland 11 123 121 105 104 100 25 341
Kacie R. Carlson United States 12 79 0.6× 90 0.7× 187 1.8× 239 2.3× 79 0.8× 23 380
Joanna E. Richards United States 10 64 0.5× 263 2.2× 125 1.2× 118 1.1× 180 1.8× 11 441
Cécile Bonnafous France 13 740 6.0× 580 4.8× 147 1.4× 151 1.5× 129 1.3× 34 1.0k
Connor H. Church United States 2 192 1.6× 181 1.5× 41 0.4× 14 0.1× 67 0.7× 2 357
Amandine Créquer United States 7 313 2.5× 144 1.2× 23 0.2× 16 0.2× 112 1.1× 7 492
Mary E. Awad United States 4 72 0.6× 82 0.7× 33 0.3× 29 0.3× 340 3.4× 5 498
Michael R. Charley United States 12 261 2.1× 91 0.8× 90 0.9× 127 1.2× 54 0.5× 16 404
Athalia R. Pyzer United States 9 200 1.6× 183 1.5× 56 0.5× 18 0.2× 156 1.6× 23 398
Isabel Longo Spain 8 160 1.3× 203 1.7× 29 0.3× 72 0.7× 93 0.9× 12 382

Countries citing papers authored by Małgorzata Bobrowicz

Since Specialization
Citations

This map shows the geographic impact of Małgorzata Bobrowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Małgorzata Bobrowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Małgorzata Bobrowicz more than expected).

Fields of papers citing papers by Małgorzata Bobrowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Małgorzata Bobrowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Małgorzata Bobrowicz. The network helps show where Małgorzata Bobrowicz may publish in the future.

Co-authorship network of co-authors of Małgorzata Bobrowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Małgorzata Bobrowicz. A scholar is included among the top collaborators of Małgorzata Bobrowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Małgorzata Bobrowicz. Małgorzata Bobrowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bobrowicz, Małgorzata, et al.. (2025). Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Biomedicines. 13(10). 2500–2500.
2.
Chang, Yun‐Tsan, Susanne Kimeswenger, Yi-Chien Tsai, et al.. (2024). MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nature Communications. 15(1). 752–752. 5 indexed citations
3.
4.
Tsai, Yi-Chien, Desislava Ignatova, Yun‐Tsan Chang, et al.. (2023). Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma. British Journal of Dermatology. 189(5). 603–611. 10 indexed citations
5.
Winiarska, Magdalena, et al.. (2022). In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies. Cancers. 15(1). 235–235. 4 indexed citations
6.
Ślusarczyk, Aleksander, et al.. (2022). Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. International Journal of Molecular Sciences. 23(3). 1501–1501. 13 indexed citations
7.
Chang, Yun‐Tsan, Christina Fassnacht, Florentia Dimitriou, et al.. (2021). Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome. OncoImmunology. 10(1). 1873530–1873530. 10 indexed citations
8.
Ślusarczyk, Aleksander, et al.. (2021). The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era. Cells. 10(6). 1511–1511. 4 indexed citations
9.
Tsai, Yi-Chien, Yun‐Tsan Chang, Alan Valaperti, et al.. (2021). Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in leukemic cutaneous T-cell lymphoma patients. European Journal of Cancer. 156. S42–S42. 2 indexed citations
10.
Bobrowicz, Małgorzata, Christina Fassnacht, Desislava Ignatova, et al.. (2020). Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020. International Archives of Allergy and Immunology. 181(10). 733–745. 34 indexed citations
11.
Saulīte, Ieva, Desislava Ignatova, Yun‐Tsan Chang, et al.. (2020). Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. OncoImmunology. 9(1). 1738797–1738797. 35 indexed citations
12.
Bobrowicz, Małgorzata, et al.. (2020). CD37 in B Cell Derived Tumors—More than Just a Docking Point for Monoclonal Antibodies. International Journal of Molecular Sciences. 21(24). 9531–9531. 19 indexed citations
13.
Sasi, Binu K., Fabiola Porro, Sven Turkalj, et al.. (2019). Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma. Leukemia. 33(10). 2416–2428. 21 indexed citations
14.
Pyrzyńska, Beata, Abdessamad Zerrouqi, Giulia Morlino, et al.. (2018). FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. OncoImmunology. 7(5). e1423183–e1423183. 18 indexed citations
15.
Domagała, Antoni, et al.. (2018). Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy. International Journal of Molecular Sciences. 19(8). 2256–2256. 72 indexed citations
16.
Domagała, Antoni, Małgorzata Bobrowicz, Joanna Stachura, et al.. (2016). Lysosomal Disruption Augments Obinutuzumab-Induced Direct Cell Death. Blood. 128(22). 2766–2766. 2 indexed citations
17.
Bojarczuk, Kamil, et al.. (2015). B-cell receptor signaling in the pathogenesis of lymphoid malignancies. Blood Cells Molecules and Diseases. 55(3). 255–265. 23 indexed citations
18.
Bobrowicz, Małgorzata, Kamil Bojarczuk, Marta Siernicka, et al.. (2014). HDAC Inhibitors As Potential New Agents Improving the Efficacy of Monoclonal Antibodies. Blood. 124(21). 3641–3641. 1 indexed citations
19.
Siernicka, Marta, Kamil Bojarczuk, Małgorzata Bobrowicz, et al.. (2014). Influence of Btk Inhibitors on Antitumor Activity of Natural Killer Cells. Blood. 124(21). 2742–2742.
20.
Pyrzyńska, Beata, Kamil Bojarczuk, Magdalena Winiarska, et al.. (2013). Inhibitors Of Src Family and AKT Regulate The Activity Of CD20 Promoter. Blood. 122(21). 1838–1838. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kacie R. Carlson Breakdown of academic impact, for papers by Joanna E. Richards Breakdown of academic impact, for papers by Cécile Bonnafous Breakdown of academic impact, for papers by Connor H. Church Breakdown of academic impact, for papers by Amandine Créquer Breakdown of academic impact, for papers by Mary E. Awad Breakdown of academic impact, for papers by Michael R. Charley Breakdown of academic impact, for papers by Athalia R. Pyzer Breakdown of academic impact, for papers by Isabel Longo
Rankless by CCL
2026